Position paper of the Italian Society for the study of Dementias (SINDEM) on the proposal of a new lexicon on Alzheimer disease (Q37953208)

25 August 2017

Position paper of the Italian Society for the study of Dementias (SINDEM) on the proposal of a new lexicon on Alzheimer disease (English)

1 reference

25 August 2017

0 references

0 references

15

1 reference

25 August 2017

Giuseppe Bruno

12

0 references

Paolo Caffarra

Paolo Caffarra

5

0 references

Benedetta Nacmias

Benedetta Nacmias

16

0 references

Antonio Federico

Antonio Federico

13

0 references

Sandro Sorbi

Sandro Sorbi

3

0 references

Elio Scarpini

Elio Scarpini

4

0 references

Carlo Caltagirone

9

Carlo Caltagirone

1 reference

25 August 2017

17

Lucilla Parnetti

1 reference

25 August 2017

11

Amalia C Bruni

1 reference

25 August 2017

1

Massimo Musicco

1 reference

25 August 2017

18

Carla Pettenati

1 reference

25 August 2017

Claudio Bruno Mariani

21

Claudio Mariani

1 reference

25 August 2017

8

Massimo Tabaton

1 reference

25 August 2017

6

Stefano Cappa

1 reference

25 August 2017

14

Carlo Ferrarese

1 reference

25 August 2017

Alessandro Padovani

2

1 reference

25 August 2017

Francesca Clerici

7

1 reference

25 August 2017

Vincenzo Bonavita

10

1 reference

25 August 2017

Giuseppe Sorrentino

19

1 reference

25 August 2017

Fabrizio Tagliavini

20

1 reference

25 August 2017

5 November 2011

1 reference

25 August 2017

Neurological Sciences

1 reference

25 August 2017

33

1 reference

25 August 2017

201-208

1 reference

25 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s10072-011-0825-8

25 August 2017

0 references

cites work

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Revising the definition of Alzheimer's disease: a new lexicon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Origins, controversies and recent developments of the MCI construct

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Vascular risk factors and dementia: how to move forward?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Educational attainment and mid-life stress as risk factors for dementia in late life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Frequent amyloid deposition without significant cognitive impairment among the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Incomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presenilin-1 gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0825-8

Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index

21 January 2018

1 reference

12 December 2020

Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

1 reference

12 December 2020

Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease

1 reference

12 December 2020

Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment

1 reference

12 December 2020

Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort

1 reference

12 December 2020

Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein.

1 reference

12 December 2020

The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease

1 reference

12 December 2020

Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42.

1 reference

12 December 2020

Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease

1 reference

12 December 2020

Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.

1 reference

12 December 2020

[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease

1 reference

12 December 2020

Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies.

1 reference

12 December 2020

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

1 reference

12 December 2020

Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment

1 reference

12 December 2020

Comparing predictors of conversion and decline in mild cognitive impairment

1 reference

12 December 2020

Category cued recall following controlled encoding as a neuropsychological tool in the diagnosis of Alzheimer's disease: a review of the evidence

1 reference

12 December 2020

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

1 reference

12 December 2020

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

12 December 2020

Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.

1 reference

12 December 2020

Age, Alzheimer disease, and brain structure

1 reference

12 December 2020

Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment

1 reference

12 December 2020

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.

1 reference

12 December 2020

Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance

1 reference

12 December 2020

An exploration of cognitive subgroups in Alzheimer's disease

1 reference

12 December 2020

Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease

1 reference

12 December 2020

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

1 reference

12 December 2020

Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia

1 reference

12 December 2020

10.1007/S10072-011-0825-8

Identifiers

DOI

1 reference

25 August 2017

1 reference